Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Patterns of arthritis medication use in a community sample.

Rosenwald K, Ertl K, Fletcher KE, Whittle J.

J Prim Care Community Health. 2012 Oct 1;3(4):272-7. doi: 10.1177/2150131912442388. Epub 2012 Apr 4.

2.

Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.

Salmon DA, Moulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA.

Pediatrics. 2004 Jun;113(6):e552-9.

PMID:
15173536
3.
4.

Preliminary description of the feasibility of using peer leaders to encourage hypertension self-management.

Hayes A, Morzinski J, Ertl K, Wurm C, Patterson L, Wilke N, Whittle J.

WMJ. 2010 Apr;109(2):85-90.

5.

Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial.

Ray WA, Stein CM, Byrd V, Shorr R, Pichert JW, Gideon P, Arnold K, Brandt KD, Pincus T, Griffin MR.

Med Care. 2001 May;39(5):425-35.

PMID:
11317091
6.

Results from a mailed promotion of medication reviews among Department of Defense beneficiaries receiving 10 or more chronic medications.

Linton A, Bacon TA, Trice S, Devine J, Cottrell L, McGinnis TJ, McAllister EB.

J Manag Care Pharm. 2010 Oct;16(8):578-92.

7.

The impact of arthritis on pain and quality of life: an Australian survey.

Hunter DJ, Riordan EA.

Int J Rheum Dis. 2014 Feb;17(2):149-55. doi: 10.1111/1756-185X.12232. Epub 2013 Nov 24.

PMID:
24267825
8.

Community-based care for the specialized management of heart failure: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(17):1-42. Epub 2009 Nov 1.

9.
10.

Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain.

Anastassopoulos KP, Chow W, Tapia CI, Baik R, Ackerman SJ, Biondi D, Kim MS.

J Manag Care Pharm. 2012 Oct;18(8):615-26.

11.

Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS).

Laba TL, Brien JA, Fransen M, Jan S.

BMC Musculoskelet Disord. 2013 May 6;14:160. doi: 10.1186/1471-2474-14-160.

12.
13.

Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong.

You JH, Wong FY, Chan FW, Wong EL, Yeoh EK.

BMC Clin Pharmacol. 2011 Nov 25;11:19. doi: 10.1186/1472-6904-11-19.

14.
15.

Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.

Kennedy J, Tuleu I, Mackay K.

J Manag Care Pharm. 2008 Jul-Aug;14(6):553-60.

16.
18.

Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(10):1-66. Epub 2005 Jun 1.

19.

Where do people go for treatment of sexually transmitted diseases?

Brackbill RM, Sternberg MR, Fishbein M.

Fam Plann Perspect. 1999 Jan-Feb;31(1):10-5.

20.

Medication acquisition across systems of care and patient-provider communication among older veterans.

Stroupe KT, Smith BM, Hogan TP, St Andre JR, Gellad WF, Weiner S, Lee TA, Burk M, Cunningham F, Piette JD, Rogers TJ, Huo Z, Weaver FM.

Am J Health Syst Pharm. 2013 May 1;70(9):804-13. doi: 10.2146/ajhp120222.

PMID:
23592363
Items per page

Supplemental Content

Write to the Help Desk